Volume 17, Issue 51 2170266
Cover Picture
Free Access

Biointerfacing Antagonizing T-Cell Inhibitory Nanoparticles Potentiate Hepatocellular Carcinoma Checkpoint Blockade Therapy (Small 51/2021)

Han Wu

Han Wu

The Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, 310014 China

School of Clinical Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, 310014 China

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, 200438 China

Search for more papers by this author
Jia-Qi Zhu

Jia-Qi Zhu

The Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, 310014 China

School of Clinical Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, 310014 China

Department of Hepatobiliary, Pancreatic and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, Zhejiang, 310014 China

Search for more papers by this author
Xin-Fei Xu

Xin-Fei Xu

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, 200438 China

Search for more papers by this author
Hao Xing

Hao Xing

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, 200438 China

Search for more papers by this author
Ming-Da Wang

Ming-Da Wang

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, 200438 China

Search for more papers by this author
Lei Liang

Lei Liang

The Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, 310014 China

School of Clinical Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, 310014 China

Department of Hepatobiliary, Pancreatic and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, Zhejiang, 310014 China

Search for more papers by this author
Chao Li

Chao Li

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, 200438 China

Search for more papers by this author
Hang-Dong Jia

Hang-Dong Jia

The Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, 310014 China

School of Clinical Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, 310014 China

Search for more papers by this author
Feng Shen

Feng Shen

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, 200438 China

Search for more papers by this author
Dong-Sheng Huang

Dong-Sheng Huang

The Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, 310014 China

School of Clinical Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, 310014 China

Search for more papers by this author
Tian Yang

Tian Yang

The Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, 310014 China

School of Clinical Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, 310014 China

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, 200438 China

Department of Hepatobiliary, Pancreatic and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, Zhejiang, 310014 China

Search for more papers by this author
First published: 23 December 2021
Citations: 2

Graphical Abstract

Biointerfacing Nanoparticles

In article number 2105237, Dong-Sheng Huang, Tian Yang, and co-workers develop a strategy of targeting therapeutic nanoparticles effectively reversing the immune-inhibiting microenvironment for enhanced PD-L1 checkpoint combination therapy. The platelet membrane cloaked nanoparticles activate the CD8+ T lymphocytes and antigen presentation of dendritic cells as well as the polarization of M1-type macrophages with the application of TIM-3 antibodies. With the collagen deposition, starvation therapy can enhance the efficacy of immunotherapy under a hypoxic microenvironment.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.